About Kola Pharma
Kola Pharma is a company based in Hyderabad (India). It operates as a B2B. Kola Pharma operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Hyderabad, India
- SectorsHealthcare
- Website kolapharma.com
- Legal Name Kola Pharma Private Limited
- Date of Incorporation 01 Dec, 2016
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹14.33 Cr
FY 2022 · +50% YoY
- Net Profit₹24.7 Lakh
FY 2022 · 2% margin
- EBITDA₹41.2 Lakh
FY 2022 · 3% margin
Associated legal entities of Kola Pharma
Kola Pharma operates through Kola Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kola Pharma Private Limited CIN U33110TG2016PTC113192 | Active | 01 Dec 2016 | Hyderabad, Telangana | ₹14.3 Cr | – | 2 | View details |
Board of directors of Kola Pharma Private Limited (Kola Pharma)
Kola Pharma Private Limited is the primary company behind Kola Pharma. The board of Kola Pharma Private Limited currently have 2 directors; the longest-serving is Meenakshi Kola Punyavati, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Meenakshi Kola Punyavati DIN 07645328 | Director | 01 Dec 2016 | 9 yrs 10 mo | Kola Pharma Private Limited |
| Sri Bhagya Sowjanya Guddati DIN 09163128 | Director | 15 Apr 2021 | 5 yrs 5 mo | Kola Pharma Private Limited |
Financials of Kola Pharma
Figures of Kola Pharma Private Limited, the primary company behind Kola Pharma, for FY 2022. Revenue was ₹14.33 Cr (+50% year on year). Net profit was ₹24.7 Lakh (2% margin). EBITDA was ₹41.2 Lakh (3% margin). Revenue has grown at a compounded annual rate of +23% over three years.
- ₹14.33 CrRevenue · FY 2022 · +50% YoY
- ₹24.7 LakhNet profit · 2% margin
- ₹41.2 LakhEBITDA · 3% margin
- ₹1 LakhPaid-up capital
- +23%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Kola Pharma Private Limited are on its company page.
Detailed financial statements for Kola Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Kola Pharma
Kola Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wuxiapptec.com | 2000 | Shanghai, China | $40M | 1,681 | Provider of CRO and CDMO services | |
| eurofins.com | 1987 | Luxembourg | – | – | Laboratory testing and contract research services are provided globally. | |
| ipsen.com | 1929 | – | – | 505 | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | |
| anipharmaceuticals.com | 1996 | Baudette, United States | – | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | |
| rednucleus.com | 2014 | Yardley, United States | – | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | |
| aptar.com | 1992 | Crystal Lake, United States | – | 232 | Regulatory support, brand differentiation, and prototyping services are provided. | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| aliadatx.com | 2021 | Boston, United States | $33M | – | Provider of drug research & development services for multiple therapeutic areas | |
| cms.net.cn | 1992 | Shenzhen, China | – | – | Generic formulations including tablets, capsules, liquids, and injectables are manufactured. |
Detailed competitors of Kola Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Kola Pharma
10 companies that operate in the same segment as Kola Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kola Pharma
Kola Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Kola Pharma, Kola Pharma Private Limited, reported revenue of ₹14.33 Cr for FY 2022, up 50% year on year.
Kola Pharma kola pharma specializes in producing pharmaceutical products, including sustained and modified release pellets, vitamin pellets, and taste-masked granules, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and pellet production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Kola Pharma's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Kola Pharma operates through Kola Pharma Private Limited.
The legal entities of Kola Pharma currently have 2 directors, including Sri Bhagya Sowjanya Guddati, Meenakshi Kola Punyavati.